Bellevue Group AG

Q3 2019 13F Holdings Report, Stock Holdings

Signature - Title
Patrik Gilli / Stefano Montalbano - CFO / Signing Authority
Location
Kuesnacht, Switzerland
Holdings as of
September 30, 2019
Value $
$5.38B
Num holdings
210
Date filed
11/14/2019, 04:57 PM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IONS, NBIX, INCY, VRTX, and SAGE.
Previous filing
Q2 2019 - Aug 14, 2019
Next filing
Q4 2019 - Feb 14, 2020
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q3 compared to 2019 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Patrik Gilli / Stefano Montalbano CFO / Signing Authority Kuesnacht, Switzerland 11/14/2019

Other Included Managers (2):

Num Name Location File Number
1 Bb Biotech Ag Schaffhausen, Switzerland 028-06964
2 Bellevue Asset Management AG Zurich 028-16892